MILLENNIUM MANAGEMENT LLC

Position in SKYE — Skye Bioscience, Inc.

CIK 1273087 NEW YORK, NY

Back to SKYE Full portfolio

Position in SKYE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$158,793

-$126,565 QoQ

Shares Held

258,200

-32.1% QoQ

Ownership

0.735%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

5 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in SKYE Over Time

Shares Held

Position Value (USD)

Derivatives in SKYE

reported options exposure · as of Sep 30, 2025

CallValue

$167,025

CallShares

42,500

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MILLENNIUM MANAGEMENT LLC holds $4,468,729,571 across 342 Biotechnology names. SKYE ranks #324 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	1,262,511	$238,677,704
2	INSM	INSMED Inc	1,157,786	$189,321,166
3	BMRN	Biomarin Pharmaceutical Inc	3,010,308	$170,052,298
4	TERN	Terns Pharmaceuticals, Inc.	3,011,558	$158,769,337
5	ALNY	Alnylam Pharmaceuticals, Inc.	447,887	$148,192,371
6	FOLD	AMICUS THERAPEUTICS, INC.	7,908,459	$114,356,317
7	ARDX	Ardelyx, Inc.	17,842,370	$106,875,796
8	BLTE	Belite Bio, Inc	570,088	$90,894,830

All Filings in SKYE

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$158,793	258,200	-32.1%	Shares	Sole	2026-05-15
2025-12-31	$285,358	380,478	-5.4%	Shares	Sole	2026-02-17
2025-09-30	$1,581,333	402,375	+846.8%	Shares	Sole	2025-11-14
2025-09-30	$167,025	42,500	-91.0%	Call	Sole	2025-11-14
2025-06-30	$1,967,647	470,729	+19.4%	Shares	Sole	2025-08-14
2024-09-30	$1,542,049	394,386	—	Shares	Sole	2024-11-14
No filing history on record for this holder in this stock.